Review: taking Zantac 150 and Lasix together


Summary

Drug interactions are reported among people who take Zantac 150 and Lasix together. This review analyzes the effectiveness and drug interactions between Zantac 150 and Lasix. It is created by eHealthMe based on reports of 8,983 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Zantac 150

Zantac 150 has active ingredients of ranitidine hydrochloride. It is often used in indigestion. (latest outcomes from Zantac 150 4,145 users)

Lasix

Lasix has active ingredients of furosemide. It is often used in high blood pressure. (latest outcomes from Lasix 106,321 users)

On Aug, 31, 2016

8,983 people who take Zantac 150, Lasix are studied.


Number of reports submitted per year:

Zantac 150 and Lasix drug interactions.

Drug effectiveness over time:

Zantac 150:
  • < 1 month: 11.0% - (1 of 9 people)
  • 1 - 6 months: 44.0% - (4 of 9 people)
  • 6 - 12 months: 40.0% - (2 of 5 people)
  • 1 - 2 years: 28.0% - (2 of 7 people)
  • 2 - 5 years: 33.0% - (2 of 6 people)
  • 5 - 10 years: 40.0% - (2 of 5 people)
  • 10+ years: 0.0% - (0 of 2 people)
  • not specified: 0.0% - (0 of 0 people)
Lasix:
  • < 1 month: 0.0% - (0 of 5 people)
  • 1 - 6 months: 57.0% - (4 of 7 people)
  • 6 - 12 months: 50.0% - (3 of 6 people)
  • 1 - 2 years: 66.0% - (2 of 3 people)
  • 2 - 5 years: 30.0% - (3 of 10 people)
  • 5 - 10 years: 50.0% - (3 of 6 people)
  • 10+ years: 16.0% - (1 of 6 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Zantac 150:
  • female: 34.0% - (11 of 32 people)
  • male: 18.0% - (2 of 11 people)
Lasix:
  • female: 34.0% - (11 of 32 people)
  • male: 45.0% - (5 of 11 people)

Drug effectiveness by age:

Zantac 150:
  • 0-1: 0.0% - (0 of 1 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (2 of 4 people)
  • 40-49: 50.0% - (2 of 4 people)
  • 50-59: 28.0% - (2 of 7 people)
  • 60+: 25.0% - (7 of 27 people)
Lasix:
  • 0-1: 0.0% - (0 of 1 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 4 people)
  • 40-49: 50.0% - (2 of 4 people)
  • 50-59: 14.0% - (1 of 7 people)
  • 60+: 48.0% - (13 of 27 people)

Most common drug interactions over time *:

< 1 month:
  • renal failure
  • pneumonia
  • pyrexia
  • multi-organ failure
  • sepsis
  • pain
  • renal failure acute
  • neutropenia
  • anxiety
  • respiratory failure
1 - 6 months:
  • pyrexia
  • abdominal pain
  • febrile neutropenia
  • diarrhoea
  • neutropenia
  • disseminated intravascular coagulation
  • pneumonia
  • enterococcal infection
  • erythema
  • hepatic vein occlusion
6 - 12 months:
  • hyponatraemia
  • malaise
  • angiodysplasia
  • hepatic encephalopathy
  • hyperkalaemia
  • white blood cell count decreased
  • dehydration
  • gastrooesophageal reflux disease
  • platelet count decreased
  • respiratory arrest
1 - 2 years:
  • hyperlipidaemia
  • osteopenia
  • anaemia
  • convulsion
  • injury
  • pneumonia
  • blood alkaline phosphatase increased
  • blood lactate dehydrogenase increased
  • cerebral infarction
  • colonic polyp
2 - 5 years:
  • osteoporosis
  • renal failure chronic
  • cardiac failure congestive
  • coronary artery disease
  • rib fracture
  • type 2 diabetes mellitus
  • upper limb fracture
  • ischaemic cardiomyopathy
  • type 1 diabetes mellitus
  • arteriosclerosis coronary artery
5 - 10 years:
  • pneumonia
  • angina pectoris
  • bronchitis
  • cellulitis
  • chronic obstructive pulmonary disease
  • multiple fractures
  • osteoporosis
  • transient ischaemic attack
  • vitamin d deficiency
  • excoriation
10+ years:
  • disease progression
  • dizziness
  • interstitial lung disease
  • anxiety
  • anxiety aggravated
  • atrial fibrillation
  • bleeding time prolonged
  • brachial pulse increased
  • chills
  • circulatory collapse
not specified:
  • nausea
  • dyspnoea
  • pain
  • cardiac failure congestive
  • anxiety
  • fatigue
  • pneumonia
  • oedema peripheral
  • pyrexia
  • fall

Most common drug interactions by gender *:

female:
  • nausea
  • dyspnoea
  • pain
  • fall
  • oedema peripheral
  • cardiac failure congestive
  • anxiety
  • vomiting
  • fatigue
  • anaemia
male:
  • dyspnoea
  • cardiac failure congestive
  • pneumonia
  • pain
  • pyrexia
  • nausea
  • anxiety
  • renal failure acute
  • fatigue
  • diarrhoea

Most common drug interactions by age *:

0-1:
  • pyrexia
  • hypotension
  • pain
  • neonatal disorder
  • oxygen saturation decreased
  • renal failure
  • tachycardia
  • bronchiolitis
  • lung disorder
  • death
2-9:
  • multi-organ failure
  • pyrexia
  • stevens johnson syndrome
  • vomiting
  • alanine aminotransferase increased
  • epistaxis
  • tachycardia
  • aspartate aminotransferase increased
  • bradycardia
  • hypotension
10-19:
  • pyrexia
  • multi-organ failure
  • cardiac arrest
  • nausea
  • renal failure acute
  • blood bilirubin increased
  • cardiac failure congestive
  • headache
  • renal failure
  • respiratory failure
20-29:
  • dyspnoea
  • pyrexia
  • nausea
  • bronchitis
  • headache
  • pain
  • hypoxia
  • vomiting
  • interstitial lung disease
  • osteonecrosis of jaw
30-39:
  • dyspnoea
  • pyrexia
  • convulsion
  • nausea
  • pneumonia
  • tremor
  • headache
  • diarrhoea
  • oedema peripheral
  • dehydration
40-49:
  • dyspnoea
  • nausea
  • anxiety
  • chest pain
  • headache
  • pain
  • pneumonia
  • dehydration
  • oedema peripheral
  • pyrexia
50-59:
  • pain
  • nausea
  • anxiety
  • depression
  • cardiac failure congestive
  • dyspnoea
  • vomiting
  • chest pain
  • pyrexia
  • fatigue
60+:
  • cardiac failure congestive
  • dyspnoea
  • nausea
  • fall
  • anaemia
  • pneumonia
  • pain
  • fatigue
  • diarrhoea
  • renal failure acute

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Zantac 150 and Lasix?

Can you answer these questions?

More questions for: Zantac 150, Lasix

You may be interested in these reviews

More reviews for: Zantac 150, Lasix

On eHealthMe, Zantac 150 (ranitidine hydrochloride) is often used to treat indigestion. Lasix (furosemide) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.